A following up study aiming to analyze the effect of DTIC+Tα1+low dose IFN-α in treating melanoma patients demonstrated response rate of 50%, associated with increase in CD4+ T cells and NK cell numbers in the peripheral blood (150). The gene discussed is CD4; the disease is melanoma.